Archives
-
WAY-100635: 5-HT1A Assay Workflows
2026-08-25
WAY-100635 enables clean dissection of 5-HT1A receptor contributions to pain, affect, cognition, and circuit activity. This workflow connects receptor binding with functional, behavioral, and imaging-oriented assays while highlighting practical controls, dosing logic, and troubleshooting decisions.
-
Palmitic acid: Protocol and QC Guide
2026-08-25
Palmitic acid (SKU N2456) provides a defined saturated long-chain fatty acid for lipid metabolism, palmitoylation, and metabolic disorder workflows. It is appropriate for solvent-based preparations but should not be selected for aqueous stock preparation or long-term solution storage without assay-specific validation.
-
ARCA Cy3 EGFP mRNA (5-moUTP) Workflow Guide
2026-08-24
Use ARCA Cy3 EGFP mRNA (5-moUTP) to separate cellular uptake from productive translation with one direct fluorescence workflow. Its Cy3 label, EGFP reporter, ARCA cap, and 5-methoxyuridine modified mRNA design support delivery optimization, localization studies, and reproducible mammalian-cell assays.
-
Pregnenolone Carbonitrile: PXR Research Workflows
2026-08-24
Pregnenolone Carbonitrile is a practical rodent PXR probe for connecting CYP3A-mediated xenobiotic clearance with cholestatic injury and fibrosis workflows. This guide translates published PCN dosing into reproducible assay design, sample handling, and troubleshooting decisions.
-
KNUCKLES Integrates Hormones in Floral Meristem Termination
2026-08-23
This Arabidopsis study identifies KNUCKLES as a chromatin-linked regulator that coordinates auxin distribution and cytokinin activity during floral meristem termination. By connecting repression of PIN1 and IPT7 with disruption of the WUS–CLV3 stem-cell circuit, the work provides a mechanistic explanation for how floral determinacy is timed.
-
Neuroligin 1 Loss Drives D2-MSN Repetitive Behavior
2026-08-22
This study identifies Neuroligin 1 deficiency in striatal dopamine D2 receptor-expressing medium spiny neurons as a cell-type-specific driver of excessive self-grooming and digging in mice. By combining behavioral analysis, D2-MSN activity manipulation, single-nucleus RNA sequencing, and protein validation, the work links neuronal hyperactivation and PKC overactivity to autistic-like repetitive behavior.
-
UTP Solution for Precision RNA Workflows
2026-08-21
UTP Solution (100 mM) supports reproducible in vitro transcription, RNA amplification, and siRNA synthesis with a high-purity, nuclease-free nucleotide source. This article connects practical RNA workflows to new mechanistic insights into TRIM66-dependent olfactory receptor regulation while clearly separating established evidence from assay recommendations.
-
Lipid-Like Nanoassemblies for Secreted ACE2 mRNA
2026-08-21
The reference study developed lipid-like nanoassemblies that protected in-vitro-transcribed mRNA, enabled high systemic translation, and produced secreted truncated ACE2 decoys with SARS-CoV-2 receptor-blocking activity. Its main contribution is a preclinical delivery strategy that connects combinatorial lipid design with transient production of an antiviral protein mimic.
-
Synthetic Receptor Microglia for Alzheimer’s Therapy
2026-08-20
Shao and colleagues developed a synthetic efferocytic receptor that redirects microglia toward amyloid-β clearance while preserving anti-inflammatory signaling. Delivered as mRNA lipid nanoparticles, the receptor improved amyloid handling, reduced inflammation and synapse loss, and improved behavioral outcomes in an Alzheimer’s disease mouse model.
-
2-Thio-dCTP and the Next Era of DNA Precision
2026-08-20
A mechanistic and translational guide to using 2-Thio-dCTP as a compact DNA perturbation tool, with practical strategies inspired by new SCP4 chromosome-stability findings.
-
Fluoroalkane Polymers for mRNA Cancer Vaccines
2026-08-19
Li and colleagues developed fluoroalkane-grafted polyethylenimine (F-PEI) as a simple cationic carrier that combines mRNA protection and intracellular delivery with deliberate TLR4-mediated immune stimulation. In mouse models, F-PEI–mRNA vaccines improved dendritic-cell activation and antigen presentation, delayed B16-OVA melanoma, and, with checkpoint blockade, suppressed MC38 tumors and recurrence.
-
Pseudo-UTP for Better mRNA Synthesis Workflows
2026-08-19
Learn how Pseudo-UTP supports pseudouridine-containing RNA production, from in vitro transcription screening to translation and stability assays. This practical guide connects nucleotide substitution decisions with vaccine, gene therapy, and troubleshooting workflows while distinguishing product-level benefits from evidence in a preclinical vaccine study.
-
Deferasirox Pharmacokinetics and Clinical Evidence
2026-08-18
Galanello, Campus, and Origa synthesize pharmacokinetic, pharmacodynamic, efficacy, and safety evidence for deferasirox across transfusion-dependent anemias. The review’s central contribution is to connect oral chelation, iron-burden biology, adherence, and monitoring requirements while showing why treatment response varies between patient groups.
-
Firefly Luciferase mRNA: LNP Assay Guide
2026-08-18
Build sensitive reporter assays with Cap1-capped, 5-moUTP modified mRNA while preserving a practical path from cell-based screening to in vivo imaging. This guide connects transcript handling, transfection, LNP formulation, normalization, and troubleshooting to evidence-based assay design.
-
Firefly Luciferase mRNA: Workflow & Optimization
2026-08-17
Firefly Luciferase mRNA (ARCA, 5-moUTP) provides a sensitive, transient readout for transfection, gene expression, cell viability, and delivery studies. This practical guide connects reporter assay design with emerging nanoparticle workflows, including lung-directed formulations and stability testing.